Left Ventricular Noncompaction

Watchlist

(log in to enable)

Retrieved

2022-04-26

Source

Gard

Trials

—

Genes

MYH7, MYBPC3, PRDM16, LMNA, ACTC1, MIB1, DTNA, LDB3, TPM1, PLEKHM2, TNNT2, MIB2, MYH7B, PKP2, YWHAE, SLC39A8, SCN5A, NONO, SDHD, SDHA, MIPEP, VCL, TRIM8, COA6, SDHAF1, TAZ, HCN4, NNT, TTN, SKI

MYH7, MYBPC3, PRDM16, LMNA, ACTC1, MIB1, DTNA, LDB3, TPM1, PLEKHM2, TNNT2, MIB2, MYH7B, PKP2, YWHAE, SLC39A8, SCN5A, NONO, SDHD, SDHA, MIPEP, VCL, TRIM8, COA6, SDHAF1, TAZ, HCN4, NNT, TTN, SKI, RYR2, KCNQ1, EMD, DMD, ACTB

Drugs

—

Interested in hearing about new therapies?

Left ventricular noncompaction (LVNC) is a rare heart condition. In LVNC the inside wall of the heart is spongy or grooved, instead of smooth. Signs and symptoms of LVNC vary, but may cause life-threatening abnormal heart rhythms and weakness of the heart muscle. Treatments, such as blood thinning medication and defibrillators, are available to control these heart symptoms. In rare cases, heart transplantation is needed.